Skip to content

Ayurvedic Treatment Protocol in the Management of Obese Polycystic Ovarian Disease

Efficacy of Virechana Karma along with Pathadi Yoga Ghanavati and Gomutra Haritaki in Obese Polycystic Ovarian Disease: a single arm open labelled clinical study

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/04/051423
Enrollment
30
Registered
2023-04-10
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N915- Oligomenorrhea, unspecified Health Condition 2: N915- Oligomenorrhea, unspecified

Interventions

None listed

Sponsors

NSTITUTE OF TEACHING AND RESEARCH IN AYURVEDA JAMNAGAR
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Married /unmarried patients in the age group of 18-40yrs 2. Patients with BMI >=30kg/m2 3. Patients with any 3 or more clinical features of PCOD like- • Amenorrhea or Oligomenorrhoea • Anovulation • Infertility (Due to anovulation) • Acne • Hirsutism (Ferryman-Gallwey scale) • Acanthosis nigricans. 4. Along with confirmation of Polycystic Ovary in USG finding

Exclusion criteria

Exclusion criteria: 1. Patients having age =40years. 2. Patient with infectious diseases of reproductive tract like tuberculosis, sexually transmitted diseases. 3. Patients suffering from Pelvic diseases like Endometriosis, PID, Fibroid uterus. 4. Organic lesions of reproductive tract like tuberculosis, carcinoma and congenital deformities. 5. Patients with history of cardiac diseases, Chronic liver disease, Uncontrolled Diabetes (>=160 mg/dl- FBS) & Hypertension (Systolic BP >=160 & Diastolic >=100mmhg), TB, etc 6. Patient with Hepatitis C, Hepatitis B 7. Patient not eligible for Virechana Karma.

Design outcomes

Primary

MeasureTime frame
It is expected that trial drug will help in the reduction of ovarian volume,weight reduction and menstrual regulation.Timepoint: 120 days

Secondary

MeasureTime frame
Trial drug will help in ovulation & conception.Timepoint: 120 days

Countries

India

Contacts

Public ContactPROF NEHA PANDYA

INSTITUTE OF TEACHING AND RESEARCH IN AYURVEDA JAMNAGAR GUJRAT

drsipikaswatibhu@gmail.com9889501569

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026